Vimarsana
Biggest News Aggregation in the World

Stefan Anker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stefan Anker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stefan Anker Today - Breaking & Trending Today

Actimed Therapeutics Closes £5M Series A Financing - Vimarsana News

Actimed Therapeutics Closes £5M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Actimed Therapeutics Closes £5M Second Tranche of £10M Seed Financing - Vimarsana News

Actimed Therapeutics Closes £5M Second Tranche of £10M Seed Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders - Vimarsana News

Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders

/PRNewswire/ -- Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer...

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum - Vimarsana News

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

(UPDATED) These drugs improve outcomes and make patients feel better, Mariell Jessup says. “I think that’s a really important story.”

Source: tctmd.com
Actimed Therapeutics secures significant new patent, extending IP coverage of its lead compound for use in key indication - Vimarsana News

Actimed Therapeutics secures significant new patent, extending IP coverage of its lead compound for use in key indication

Provides extended UK patent coverage relating to lead compound S-pindolol benzoate (ACM-001.1) to 2040. International patent application also filed in March 2021. LONDON, May 4, 2022 /PRNewswire/